Skip to main content

Originals

Research-backed writing from the Nila desk.

Plain answers from people who've read the studies. The editorial body is always sponsor-blind. Every piece is graded and dated, with the original research linked.

The latest three, open in full

Grade C — emerging or limited evidence

Emerging or limited evidence. Useful context, but treat conclusions as provisional.

October 22, 2026 · checked October 22, 2026 · 8 min read

Human-centred evidence: start with the person, not the snapshot

By Erin Beattie, founder of Hello Nila

Most of the answers I was offered in menopause came from a single moment. A blood result from one morning, in a body whose ovaries were already gone, read as if one number could tell the whole story. A sleep score from one night, from a gadget that was never tested on a body like mine. A short appointment, where I…

Read the full piece
Grade C — emerging or limited evidence

Emerging or limited evidence. Useful context, but treat conclusions as provisional.

October 13, 2026 · checked October 13, 2026 · 4 min read

What happened to everyone else's data

By Erin Beattie, founder of Hello Nila

I read thirteen privacy enforcement cases this year. Health apps, mostly. The details blur after a while, but the shape of every case is the same. A company promises, in plain friendly language, that your health data stays private. Then the data quietly goes somewhere else. The record GoodRx told users it would never…

Read the full piece
Grade C — emerging or limited evidence

Emerging or limited evidence. Useful context, but treat conclusions as provisional.

October 13, 2026 · checked October 13, 2026 · 4 min read

Menopause isn't pink

By Erin Beattie, founder of Hello Nila

The pharmacy aisle told me who menopause was for before any doctor did. Pink boxes. Soft flowers. A woman laughing alone with salad, which has never been anyone's actual response to a hot flash. The woman on the box is 51, cisgender, her timing textbook. She's real, and she deserves good care. She's also a fraction of…

Read the full piece

9 pieces, all free

  • Grade C — emerging or limited evidence

    Emerging or limited evidence. Useful context, but treat conclusions as provisional.

    October 22, 2026 · checked October 22, 2026 · 8 min read

    Human-centred evidence: start with the person, not the snapshot

    Menopause can't be understood in a snapshot. You can only understand it over time, through the person living it. What the research actually says about single readings, trajectories and self-report, and the standard Nila is built on.

    Read
  • Grade C — emerging or limited evidence

    Emerging or limited evidence. Useful context, but treat conclusions as provisional.

    October 13, 2026 · checked October 13, 2026 · 4 min read

    What happened to everyone else's data

    What thirteen health-app privacy cases reveal about the gap between promise and practice.

    Read
  • Grade C — emerging or limited evidence

    Emerging or limited evidence. Useful context, but treat conclusions as provisional.

    October 13, 2026 · checked October 13, 2026 · 4 min read

    Menopause isn't pink

    The pink box in the pharmacy aisle never had much to say to me. A design note on the doorways, language and colours that make Nila a wider place to land.

    Read
  • Grade C — emerging or limited evidence

    Emerging or limited evidence. Useful context, but treat conclusions as provisional.

    October 13, 2026 · checked October 13, 2026 · 9 min read

    Can a spit test tell you you're in perimenopause?

    What hormone-testing kits can measure, what they can't establish on their own, and where a thoughtful conversation about testing fits.

    Read
  • Grade C — emerging or limited evidence

    Emerging or limited evidence. Useful context, but treat conclusions as provisional.

    September 25, 2026 · checked September 25, 2026 · 17 min read

    When hormones shift, mental health shifts with them

    Hormone swings can shake your mood, and the risk gathers around the change itself: perimenopause, the weeks after birth, surgical menopause, and any time hormone therapy is interrupted. Who is vulnerable, and how to catch it early.

    Read
  • Grade C — emerging or limited evidence

    Emerging or limited evidence. Useful context, but treat conclusions as provisional.

    September 3, 2026 · checked September 3, 2026 · 7 min read

    The 228% isn't the story. Why it took this long is.

    Manulife Canada reports hormone therapy claims among women 45 to 54 rose 228% between 2021 and 2025. That number is real, and it's being read on the wrong scale. A response from the Nila research desk.

    Read
  • Grade C — emerging or limited evidence

    Emerging or limited evidence. Useful context, but treat conclusions as provisional.

    August 26, 2026 · checked August 26, 2026 · 9 min read

    Your ring doesn't know how last night felt

    Wearables are everywhere in midlife health now. Here's what the validation research says about sleep tracking, where midlife sits in that evidence, the rules we set before bringing Apple Health and Health Connect data into Nila, and how those rules are built into the product itself.

    Read
  • Grade C — emerging or limited evidence

    Emerging or limited evidence. Useful context, but treat conclusions as provisional.

    July 9, 2026 · checked July 8, 2026 · 14 min read

    Menopause care in Canada is stretched thin. Here’s where that leaves you and where we’ve decided to stand.

    The president of the Society of Obstetricians and Gynecologists of Canada has publicly named the gap in menopause care. A national women’s health framework bill is moving through the Senate. In the years it’ll take to close the gap, this is what we’re seeing and the line we’re trying to hold.

    Read
  • Grade C — emerging or limited evidence

    Emerging or limited evidence. Useful context, but treat conclusions as provisional.

    July 5, 2026 · checked July 8, 2026 · 12 min read

    The patient at the centre of the record doesn't exist

    Most health data about menopause is built around a very specific woman: 51, cisgender, textbook timing. If you're not her, you're often invisible to the system. What the research actually says, what most apps miss, and what Nila is doing differently.

    Read

Every Original stays free, forever.

With Premium, the pieces you read save to your account, link to your journal patterns, and go into a doctor-ready export with citations.

Save articles I read, try Premium free

Every Original carries the same A to D grade as the Research shelf. Most are essays and analysis, so they're graded C, expert opinion, with the studies they draw on linked inside. See how we grade evidence